Author

Miles Parkes 1

1 Gastroenterology,Addenbrooke's Hospital,Cambridge,United Kingdom

ACETARSOL SUPPOSITORIES ARE AN EFFECTIVE AND WELL TOLERATED TREATMENT FOR REFRACTORY PROCTITIS: A COHORT STUDY

Christopher John Kiely, Angela Clark, Joya Bhattacharyya, James C. Lee, Miles Parkes

GENOME-WIDE ANALYSIS OF 53,400 PEOPLE WITH IRRITABLE BOWEL SYNDROME HIGHLIGHTS SHARED PATHWAYS WITH NEUROAFFECTIVE TRAITS

Chris Eijsbouts, Tenghao Zheng, Nicholas A Kennedy, Ferdinando Bonfiglio, Carl Anderson, Joanne Holliday, Jing Shi, Suyash Shringarpure, Alexandru-Ioan Voda, Gianrico Farrugia, Andre Franke, Matthias Hübenthal, Goncalo Abecasis, Matthew Zawistowski, Anne Heidi Skogholt, Kristian Hveem, Tonu Esko, Maris Teder-Laving, Alexa

PROFILE TRIAL: PREDICTING OUTCOMES FOR CROHN’S DISEASE USING A MOLECULAR BIOMARKER

James C. Lee, Daniele Biasci, Nurulamin M Noor, Eoin F. McKinney, Tariq Ahmad, Nina R Lewis, Ailsa L Hart, Paul A Lyons, Miles Parkes, Kenneth GC Smith

THERAPEUTIC DRUG MONITORING OF INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE

Sai Chuah, Miles Parkes

TRANSCRIPTOMIC PROFILES FOR HUMAN INTESTINAL T CELLS REVEAL NOVEL PATHWAYS OF REGULATION AND INTERACTIONS WITH GENETIC RISK FOR BOTH GASTROINTESTINAL AND EXTRAINTESTINAL INFLAMMATORY DISEASE.

Tim Raine, Jimmy Liu, Carl Anderson, Miles Parkes, Arthur Kaser

Item 1 - 5 / 9
1